SCYX vs SEPN

SCYNEXIS, Inc. vs Septerna, Inc. — Valuation Comparison 2026

SCYX

Pharmaceutical Preparations
SCYNEXIS, Inc.
Quality
5.6
out of 10
Value Trap
30
LOW
Price
$0.70
Last close
Models
10/13
Active
VS

SEPN

Pharmaceutical Preparations
Septerna, Inc.
Quality
7.0
out of 10
Value Trap
12
SAFE
Price
$30.20
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType SCYX Fair ValueSCYX Upside SEPN Fair ValueSEPN Upside
Bayesian DCF Intrinsic $0.38 -46.8% $15.60 -48.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.84 +19.7% $4.39 -85.5%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for SCYX vs SEPN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SCYX vs SEPN — Which Stock Is More Undervalued?

SEPN scores higher with a 7.0/10 quality rating vs SCYX's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing SCYNEXIS, Inc. (SCYX) and Septerna, Inc. (SEPN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SCYX currently trades at $0.70 with a QOC of 5.6/10, while SEPN trades at $30.20 with a QOC of 7.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).